Filter
1246
Text search:
Pulmonary
Tuberculosis
Featured
153
300
Language
Document type
831
151
148
54
19
18
14
3
3
2
1
1
1
Countries / Regions
79
57
39
39
38
29
27
24
20
18
17
15
15
15
15
15
14
14
14
13
13
12
12
11
11
11
10
10
10
9
9
9
7
7
7
6
6
6
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
477
134
68
35
15
14
14
Toolboxes
523
116
53
46
20
20
18
18
15
15
12
12
11
10
10
9
2
2
1
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several
...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an
...
2nd edition
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key impro
...
Stop TB Communicable Diseases
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Research
Emerging Infectious Diseases Vol. 12, No. 5, May 2006
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Update 2021; Immunization, Vaccines and Biologicals
Opinión y análisis / Opinion and analysis
Rev Panam Salud Publica 38(3), 2015; Int J Tuberc Lung Dis. 2015;19(4):375–80
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Основная цель этого Руководства состоит в том, чтобы очертить рамки методов, используемых для оценки распространенности ВИЧ-инфекции среди больных туберкулезом и
...
braz j infect dis 2 0 1 7;2 1(2):162–170
http://dx.doi.org/10.1016/j.bjid.2016.11.006
1413-8670/© 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
